Loss of heterozygosity at chromosome 9p in ductal carcinoma in situ and invasive carcinoma of the breast
1998

Loss of Heterozygosity in Breast Cancer

Sample size: 23 publication Evidence: moderate

Author Information

Author(s): KL Marsh, JM Varley

Primary Institution: CRC Department of Cancer Genetics, Paterson Institute for Cancer Research

Hypothesis

The study aims to determine the significance of loss of heterozygosity (LOH) at chromosome 9p in ductal carcinoma in situ (DCIS) and invasive breast cancer.

Conclusion

The study found that higher levels of loss of heterozygosity were observed in ductal carcinoma in situ compared to invasive breast cancer, suggesting that DCIS may be a precursor to invasive cancer.

Supporting Evidence

  • Twelve of the thirteen DCIS cases studied showed loss of at least one marker on chromosome 9p.
  • Levels of loss in the DCIS cases were significantly higher than in invasive breast tumors.
  • Genetic alterations in DCIS lesions are similar to those found in invasive breast carcinoma.

Takeaway

The study looked at breast cancer samples and found that early-stage tumors (DCIS) often show more genetic changes than later-stage tumors, which might help us understand how breast cancer develops.

Methodology

The study analyzed tumor samples for loss of heterozygosity using microdissection and PCR amplification techniques.

Limitations

The study's sample size was relatively small, and the results may not be generalizable to all breast cancer cases.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication